{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:12:51Z","timestamp":1789197171272,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12010-026-05722-w","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:13:47Z","timestamp":1779336827000},"page":"6431-6451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["JARID1B-Mediated H3K4me3 Demethylation Promotes Cisplatin Resistance in Oral Squamous Cell Carcinoma Cells via the miR-495-3p\/FUBP1 Axis"],"prefix":"10.1007","volume":"198","author":[{"given":"Jixiong","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7840-2047","authenticated-orcid":false,"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"1","key":"5722_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023). Oral squamous cell carcinomas: state of the field and emerging directions. International Journal Of Oral Science, 15(1), 44. https:\/\/doi.org\/10.1038\/s41368-023-00249-w","journal-title":"International Journal Of Oral Science"},{"key":"5722_CR2","doi-asserted-by":"publisher","first-page":"105451","DOI":"10.1016\/j.oraloncology.2021.105451","volume":"121","author":"A Chamoli","year":"2021","unstructured":"Chamoli, A., Gosavi, A. S., Shirwadkar, U. P., Wangdale, K. V., Behera, S. K., Kurrey, N. K., Kalia, K., & Mandoli, A. (2021). Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncology, 121, 105451. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105451","journal-title":"Oral Oncology"},{"key":"5722_CR3","doi-asserted-by":"publisher","first-page":"112760","DOI":"10.1016\/j.ejmech.2020.112760","volume":"208","author":"YD Fu","year":"2020","unstructured":"Fu, Y. D., Huang, M. J., Guo, J. W., You, Y. Z., Liu, H. M., Huang, L. H., & Yu, B. (2020). Targeting histone demethylase KDM5B for cancer treatment. European Journal Of Medicinal Chemistry, 208, 112760. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112760","journal-title":"European Journal Of Medicinal Chemistry"},{"issue":"13","key":"5722_CR4","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.3390\/cancers14133270","volume":"14","author":"Y Ohguchi","year":"2022","unstructured":"Ohguchi, Y., & Ohguchi, H. (2022). Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator? Cancers (Basel), 14(13), 3270. https:\/\/doi.org\/10.3390\/cancers14133270","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5722_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13072-025-00624-3","volume":"18","author":"X Chen","year":"2025","unstructured":"Chen, X., Chen, M., Gu, X., Zhou, Q., Zhao, Y., Yang, Y., Zhang, H., & Yang, X. (2025). Roles of KDM5 demethylases in therapeutic resistance of cancers. Epigenetics Chromatin, 18(1), 61. https:\/\/doi.org\/10.1186\/s13072-025-00624-3","journal-title":"Epigenetics Chromatin"},{"key":"5722_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejmech.2018.10.040","volume":"161","author":"YC Zheng","year":"2019","unstructured":"Zheng, Y. C., Chang, J., Wang, L. C., Ren, H. M., Pang, J. R., & Liu, H. M. (2019). Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target. European Journal Of Medicinal Chemistry, 161, 131\u2013140. https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.040","journal-title":"European Journal Of Medicinal Chemistry"},{"issue":"5","key":"5722_CR7","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3892\/or.2015.3849","volume":"33","author":"Z Cui","year":"2015","unstructured":"Cui, Z., Song, L., Hou, Z., Han, Y., Hu, Y., Wu, Y., Chen, W., & Mao, L. (2015). PLU-1\/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma. Oncology Reports, 33(5), 2454\u20132460. https:\/\/doi.org\/10.3892\/or.2015.3849","journal-title":"Oncology Reports"},{"issue":"14","key":"5722_CR8","doi-asserted-by":"publisher","first-page":"12723","DOI":"10.18632\/oncotarget.3713","volume":"6","author":"B Tang","year":"2015","unstructured":"Tang, B., Qi, G., Tang, F., Yuan, S., Wang, Z., Liang, X., Li, B., Yu, S., Liu, J., Huang, Q., Wei, Y., Zhai, R., Lei, B., Yu, H., Jiao, X., & He, S. (2015). JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN\/AKT signaling in hepatocellular carcinoma cells. Oncotarget, 6(14), 12723\u201312739. https:\/\/doi.org\/10.18632\/oncotarget.3713","journal-title":"Oncotarget"},{"issue":"1","key":"5722_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12964-020-00660-4","volume":"18","author":"D Huang","year":"2020","unstructured":"Huang, D., Xiao, F., Hao, H., Hua, F., Luo, Z., Huang, Z., Li, Q., Chen, S., Cheng, X., Zhang, X., Fang, W., Hu, X., & Liu, F. (2020). JARID1B promotes colorectal cancer proliferation and Wnt\/beta-catenin signaling via decreasing CDX2 level. Cell Commun Signal, 18(1), 169. https:\/\/doi.org\/10.1186\/s12964-020-00660-4","journal-title":"Cell Commun Signal"},{"issue":"1","key":"5722_CR10","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/cancers3011383","volume":"3","author":"LP Blair","year":"2011","unstructured":"Blair, L. P., Cao, J., Zou, M. R., Sayegh, J., & Yan, Q. (2011). Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer. Cancers (Basel), 3(1), 1383\u20131404. https:\/\/doi.org\/10.3390\/cancers3011383","journal-title":"Cancers (Basel)"},{"issue":"6","key":"5722_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ccell.2018.10.014","volume":"34","author":"K Hinohara","year":"2018","unstructured":"Hinohara, K., Wu, H. J., Vigneau, S., McDonald, T. O., Igarashi, K. J., Yamamoto, K. N., Madsen, T., Fassl, A., Egri, S. B., Papanastasiou, M., Ding, L., Peluffo, G., Cohen, O., Kales, S. C., Lal-Nag, M., Rai, G., Maloney, D. J., Jadhav, A., Simeonov, A., Wagle, N., Brown, M., Meissner, A., Sicinski, P., Jaffe, J. D., Jeselsohn, R., Gimelbrant, A. A., Michor, F., & Polyak, K. (2018). KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell, 34(6), 939\u2013953e939. https:\/\/doi.org\/10.1016\/j.ccell.2018.10.014","journal-title":"Cancer Cell"},{"issue":"1","key":"5722_CR12","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1038\/s41598-023-44536-2","volume":"13","author":"D Wang","year":"2023","unstructured":"Wang, D., Zhang, Y., Liao, Z., Ge, H., Gungor, C., & Li, Y. (2023). KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas. Scientific Reports, 13(1), 18250. https:\/\/doi.org\/10.1038\/s41598-023-44536-2","journal-title":"Scientific Reports"},{"issue":"6","key":"5722_CR13","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1074\/jbc.M115.698449","volume":"291","author":"JR Horton","year":"2016","unstructured":"Horton, J. R., Engstrom, A., Zoeller, E. L., Liu, X., Shanks, J. R., Zhang, X., Johns, M. A., Vertino, P. M., Fu, H., & Cheng, X. (2016). Characterization of a Linked Jumonji Domain of the KDM5\/JARID1 Family of Histone H3 Lysine 4 Demethylases. Journal Of Biological Chemistry, 291(6), 2631\u20132646. https:\/\/doi.org\/10.1074\/jbc.M115.698449","journal-title":"Journal Of Biological Chemistry"},{"issue":"3","key":"5722_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41418-024-01257-x","volume":"31","author":"B Zhang","year":"2024","unstructured":"Zhang, B., Li, J., Wang, Y., Liu, X., Yang, X., Liao, Z., Deng, S., Deng, Y., Zhou, Z., Tian, Y., Wei, W., Meng, J., Hu, Y., Wan, C., Zhang, Z., Huang, F., Wen, L., Wu, B., Sun, Y., Li, Y., & Yang, K. (2024). Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16\/TOP2A axis. Cell Death And Differentiation, 31(3), 309\u2013321. https:\/\/doi.org\/10.1038\/s41418-024-01257-x","journal-title":"Cell Death And Differentiation"},{"issue":"1","key":"5722_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2015.07.003","volume":"368","author":"CS Lin","year":"2015","unstructured":"Lin, C. S., Lin, Y. C., Adebayo, B. O., Wu, A., Chen, J. H., Peng, Y. J., Cheng, M. F., Lee, W. H., Hsiao, M., Chao, T. Y., & Yeh, C. T. (2015). Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Cancer Letters, 368(1), 36\u201345. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.003","journal-title":"Cancer Letters"},{"key":"5722_CR16","doi-asserted-by":"publisher","first-page":"111528","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen, B. M., Hidayat, H. J., Salihi, A., Sabir, D. K., Taheri, M., & Ghafouri-Fard, S. (2021). MicroRNA: A signature for cancer progression. Biomedicine & Pharmacotherapy, 138, 111528. https:\/\/doi.org\/10.1016\/j.biopha.2021.111528","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"5722_CR17","doi-asserted-by":"publisher","first-page":"154610","DOI":"10.1016\/j.prp.2023.154610","volume":"248","author":"H Huldani","year":"2023","unstructured":"Huldani, H., Alshahrani, S. H., Almajidi, Y. Q., Romero-Parra, R. M., Hjazi, A., Alsaab, H. O., Oudaha, K. H., Hussien, B. M., Ahmed, M., & Fard, S. R. H. (2023). miR-495-3p as a promising tumor suppressor in human cancers. Pathology, Research And Practice, 248, 154610. https:\/\/doi.org\/10.1016\/j.prp.2023.154610","journal-title":"Pathology, Research And Practice"},{"issue":"7","key":"5722_CR18","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/cbin.11581","volume":"45","author":"Z Yang","year":"2021","unstructured":"Yang, Z., Chen, W., Wang, Y., Qin, M., & Ji, Y. (2021). CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression. Cell Biology International, 45(7), 1423\u20131435. https:\/\/doi.org\/10.1002\/cbin.11581","journal-title":"Cell Biology International"},{"issue":"1","key":"5722_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-020-01735-3","volume":"39","author":"C Du","year":"2020","unstructured":"Du, C., Lv, C., Feng, Y., & Yu, S. (2020). Activation of the KDM5A\/miRNA-495\/YTHDF2\/m6A-MOB3B axis facilitates prostate cancer progression. Journal Of Experimental & Clinical Cancer Research : Cr, 39(1), 223. https:\/\/doi.org\/10.1186\/s13046-020-01735-3","journal-title":"Journal Of Experimental & Clinical Cancer Research : Cr"},{"issue":"2","key":"5722_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00018-018-2933-6","volume":"76","author":"L Debaize","year":"2019","unstructured":"Debaize, L., & Troadec, M. B. (2019). The master regulator FUBP1: its emerging role in normal cell function and malignant development. Cellular And Molecular Life Sciences, 76(2), 259\u2013281. https:\/\/doi.org\/10.1007\/s00018-018-2933-6","journal-title":"Cellular And Molecular Life Sciences"},{"issue":"2","key":"5722_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/1724600820912252","volume":"35","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Liu, J., Geng, N., & Feng, C. (2020). Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma. International Journal Of Biological Markers, 35(2), 56\u201365. https:\/\/doi.org\/10.1177\/1724600820912252","journal-title":"International Journal Of Biological Markers"},{"issue":"18","key":"5722_CR22","doi-asserted-by":"publisher","first-page":"e71053","DOI":"10.1096\/fj.202403371R","volume":"39","author":"Y Liang","year":"2025","unstructured":"Liang, Y., Cao, Y., Sun, Y., Zhong, J., Du, Y., Liu, L., Hu, X., Li, J., & Zhang, G. (2025). PTBP1 Reduces KLF9 mRNA Stability and Upregulates FUBP1 to Promote Colorectal Cancer Stemness and Cisplatin Resistance. The Faseb Journal, 39(18), e71053. https:\/\/doi.org\/10.1096\/fj.202403371R","journal-title":"The Faseb Journal"},{"issue":"3","key":"5722_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.34172\/joddd.2021.036","volume":"15","author":"F Atashi","year":"2021","unstructured":"Atashi, F., Vahed, N., Emamverdizadeh, P., Fattahi, S., & Paya, L. (2021). Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review. J Dent Res Dent Clin Dent Prospects, 15(3), 219\u2013225. https:\/\/doi.org\/10.34172\/joddd.2021.036","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"key":"5722_CR24","doi-asserted-by":"publisher","first-page":"761379","DOI":"10.3389\/fonc.2021.761379","volume":"11","author":"Y Cheng","year":"2021","unstructured":"Cheng, Y., Li, S., Gao, L., Zhi, K., & Ren, W. (2021). The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma. Frontiers In Oncology, 11, 761379. https:\/\/doi.org\/10.3389\/fonc.2021.761379","journal-title":"Frontiers In Oncology"},{"issue":"1","key":"5722_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7150\/jca.22145","volume":"9","author":"D Huang","year":"2018","unstructured":"Huang, D., Qiu, Y., Li, G., Liu, C., She, L., Zhang, D., Chen, X., Zhu, G., Zhang, X., Tian, Y., & Liu, Y. (2018). KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck. Journal Of Cancer, 9(1), 198\u2013204. https:\/\/doi.org\/10.7150\/jca.22145","journal-title":"Journal Of Cancer"},{"issue":"5","key":"5722_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mc.23695","volume":"63","author":"W Yuan","year":"2024","unstructured":"Yuan, W., Hu, J., Wang, M., Li, G., Lu, S., Qiu, Y., Liu, C., & Liu, Y. (2024). KDM5B promotes metastasis and epithelial-mesenchymal transition via Wnt\/beta-catenin pathway in squamous cell carcinoma of the head and neck. Molecular Carcinogenesis, 63(5), 885\u2013896. https:\/\/doi.org\/10.1002\/mc.23695","journal-title":"Molecular Carcinogenesis"},{"issue":"1","key":"5722_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13062-024-00499-6","volume":"19","author":"Y Liang","year":"2024","unstructured":"Liang, Y., Zhong, H., Zhao, Y., Tang, X., Pan, C., Sun, J., & Sun, J. (2024). Epigenetic mechanism of RBM15 in affecting cisplatin resistance in laryngeal carcinoma cells by regulating ferroptosis. Biology Direct, 19(1), 57. https:\/\/doi.org\/10.1186\/s13062-024-00499-6","journal-title":"Biology Direct"},{"issue":"11","key":"5722_CR28","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s12094-021-02687-6","volume":"23","author":"J Tang","year":"2021","unstructured":"Tang, J., Pan, H., Wang, W., Qi, C., Gu, C., Shang, A., & Zhu, J. (2021). MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer. Clinical And Translational Oncology, 23(11), 2323\u20132334. https:\/\/doi.org\/10.1007\/s12094-021-02687-6","journal-title":"Clinical And Translational Oncology"},{"issue":"1","key":"5722_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12935-023-03068-5","volume":"23","author":"X Xu","year":"2023","unstructured":"Xu, X., Song, B., Zhang, Q., Qi, W., & Xu, Y. (2023). Hsa_circ_0022383 promote non-small cell lung cancer tumorigenesis through regulating the miR-495-3p\/KPNA2 axis. Cancer Cell International, 23(1), 282. https:\/\/doi.org\/10.1186\/s12935-023-03068-5","journal-title":"Cancer Cell International"},{"issue":"5","key":"5722_CR30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3892\/ijo.2020.5128","volume":"57","author":"J Qian","year":"2020","unstructured":"Qian, J., Garg, A., Li, F., Shen, Q., & Xiao, K. (2020). lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR\u2013495\u20133p\/MYCBP axis. International Journal Of Oncology, 57(5), 1157\u20131168. https:\/\/doi.org\/10.3892\/ijo.2020.5128","journal-title":"International Journal Of Oncology"},{"issue":"18","key":"5722_CR31","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.26355\/eurrev_202009_23024","volume":"24","author":"GM Huang","year":"2020","unstructured":"Huang, G. M., Zang, H. L., Geng, Y. X., & Li, Y. H. (2020). LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p. European Review For Medical And Pharmacological Sciences, 24(18), 9408\u20139415. https:\/\/doi.org\/10.26355\/eurrev_202009_23024","journal-title":"European Review For Medical And Pharmacological Sciences"},{"issue":"6","key":"5722_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/1120009X.2022.2162218","volume":"35","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Cui, X., Qu, H., & Zhang, Y. (2023). Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression. Journal Of Chemotherapy, 35(6), 550\u2013562. https:\/\/doi.org\/10.1080\/1120009X.2022.2162218","journal-title":"Journal Of Chemotherapy"},{"issue":"14","key":"5722_CR33","doi-asserted-by":"publisher","first-page":"8916","DOI":"10.1002\/jsfa.13718","volume":"104","author":"M Feng","year":"2024","unstructured":"Feng, M., Fan, X., Shi, J., Shan, S., Li, S., He, S., Ding, M., & Li, Z. (2024). Terpenoids from quinoa reverse drug resistance of colon cancer by upregulating miR-495-3p. Journal Of The Science Of Food And Agriculture, 104(14), 8916\u20138927. https:\/\/doi.org\/10.1002\/jsfa.13718","journal-title":"Journal Of The Science Of Food And Agriculture"},{"issue":"1","key":"5722_CR34","doi-asserted-by":"publisher","first-page":"BSR20210245","DOI":"10.1042\/BSR20210245","volume":"42","author":"M Liu","year":"2022","unstructured":"Liu, M., Yang, J., Lv, W., Wang, S., Du, T., Zhang, K., Wu, Y., & Feng, X. (2022). Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT\/mTOR pathway. Bioscience Reports, 42(1), BSR20210245. https:\/\/doi.org\/10.1042\/BSR20210245","journal-title":"Bioscience Reports"},{"key":"5722_CR35","doi-asserted-by":"publisher","first-page":"671392","DOI":"10.3389\/fgene.2021.671392","volume":"12","author":"Y Meng","year":"2021","unstructured":"Meng, Y., & Li, X. (2021). Expression and Prognosis Analysis of SUMOylation Regulators in Oral Squamous Cell Carcinoma Based on High-Throughput Sequencing. Frontiers In Genetics, 12, 671392. https:\/\/doi.org\/10.3389\/fgene.2021.671392","journal-title":"Frontiers In Genetics"},{"issue":"7","key":"5722_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.7150\/jca.9207","volume":"5","author":"G Zhu","year":"2014","unstructured":"Zhu, G., Cai, G., Liu, Y., Tan, H., Yu, C., Huang, M., Wei, M., Li, S., Cui, X., Huang, D., Tian, Y., & Zhang, X. (2014). Quantitative iTRAQ LC-MS\/MS Proteomics Reveals Transcription Factor Crosstalk and Regulatory Networks in Hypopharyngeal Squamous Cell Carcinoma. Journal Of Cancer, 5(7), 525\u2013536. https:\/\/doi.org\/10.7150\/jca.9207","journal-title":"Journal Of Cancer"},{"issue":"3","key":"5722_CR37","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1002\/mco2.257","volume":"4","author":"Q Ma","year":"2023","unstructured":"Ma, Q., Sun, J., Wang, H., Zhou, C., Li, C., Wu, Y., Wen, Y., Zhang, X., Ren, X., Guo, Z., Gong, L., & Zhang, W. (2023). Far upstream element-binding protein 1 confers lobaplatin resistance by transcriptionally activating PTGES and facilitating the arachidonic acid metabolic pathway in osteosarcoma. MedComm (2020), 4(3), e257. https:\/\/doi.org\/10.1002\/mco2.257","journal-title":"MedComm (2020)"},{"issue":"21","key":"5722_CR38","doi-asserted-by":"publisher","first-page":"11214","DOI":"10.1093\/nar\/gky756","volume":"46","author":"L Debaize","year":"2018","unstructured":"Debaize, L., Jakobczyk, H., Avner, S., Gaudichon, J., Rio, A. G., Serandour, A. A., Dorsheimer, L., Chalmel, F., Carroll, J. S., Zornig, M., Rieger, M. A., Delalande, O., Salbert, G., Galibert, M. D., Gandemer, V., & Troadec, M. B. (2018). Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation. Nucleic Acids Research, 46(21), 11214\u201311228. https:\/\/doi.org\/10.1093\/nar\/gky756","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"5722_CR39","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.bbrc.2018.10.009","volume":"505","author":"P Fan","year":"2018","unstructured":"Fan, P., Ma, J., & Jin, X. (2018). Far upstream element-binding protein 1 is up-regulated in pancreatic cancer and modulates immune response by increasing programmed death ligand 1. Biochemical And Biophysical Research Communications, 505(3), 830\u2013836. https:\/\/doi.org\/10.1016\/j.bbrc.2018.10.009","journal-title":"Biochemical And Biophysical Research Communications"},{"issue":"1","key":"5722_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13148-018-0533-9","volume":"10","author":"KT Kuo","year":"2018","unstructured":"Kuo, K. T., Huang, W. C., Bamodu, O. A., Lee, W. H., Wang, C. H., Hsiao, M., Wang, L., & Yeh, C. (2018). Histone demethylase JARID1B\/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor. Clin Epigenetics, 10(1), 107. https:\/\/doi.org\/10.1186\/s13148-018-0533-9","journal-title":"Clin Epigenetics"},{"issue":"28","key":"5722_CR41","doi-asserted-by":"publisher","first-page":"e2421159122","DOI":"10.1073\/pnas.2421159122","volume":"122","author":"C Fierro","year":"2025","unstructured":"Fierro, C., Giovannini, S., Moriconi, V., Fiorilli, C., Panatta, E., Frezza, V., Corigliano, F., Pecorari, R., Li, Y., Zhou, J., Delvecchio, V. S., Smirnov, A., Manteiga, J. M. G., Brendolan, A., Zhang, J., Shi, Y., Amelio, I., Candi, E., Melino, G., & Bernassola, F. (2025). The WWP1-JARID1B axis sustains acute myeloid leukemia chemoresistance. Proc Natl Acad Sci U S A, 122(28), e2421159122. https:\/\/doi.org\/10.1073\/pnas.2421159122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5722_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/1535-7163.MCT-18-0395","volume":"18","author":"X Liu","year":"2019","unstructured":"Liu, X., Zhang, S. M., McGeary, M. K., Krykbaeva, I., Lai, L., Jansen, D. J., Kales, S. C., Simeonov, A., Hall, M. D., Kelly, D. P., Bosenberg, M. W., & Yan, Q. (2019). KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations. Molecular Cancer Therapeutics, 18(3), 706\u2013717. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0395","journal-title":"Molecular Cancer Therapeutics"},{"issue":"8","key":"5722_CR43","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3390\/cancers12082121","volume":"12","author":"A Jose","year":"2020","unstructured":"Jose, A., Shenoy, G. G., Rodrigues, S., Kumar, G., Munisamy, N. A. N., Thomas, M., Kolesar, L., Rai, J., Rao, G., P. P. N., & Rao, M. (2020). Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy. Cancers (Basel), 12(8), 2121. https:\/\/doi.org\/10.3390\/cancers12082121","journal-title":"Cancers (Basel)"},{"issue":"21","key":"5722_CR44","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1038\/s41388-022-02311-z","volume":"41","author":"R He","year":"2022","unstructured":"He, R., Xhabija, B., Gopi, L. K., Kurup, J. T., Xu, Z., Liu, Z., & Kidder, B. L. (2022). H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity. Oncogene, 41(21), 2958\u20132972. https:\/\/doi.org\/10.1038\/s41388-022-02311-z","journal-title":"Oncogene"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05722-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05722-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05722-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:50:02Z","timestamp":1789195802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05722-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5722"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05722-w","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was authorized by the Medical Ethics Committee of Beijing Friendship Hospital, Capital Medical University, and all participants or their families provided informed consent and signed written consent forms. All animal studies were approved by the Ethics Committee of Beijing Friendship Hospital, Capital Medical University and conducted in compliance with the Guide for the Care and Use of Laboratory Animals (NIH, Bethesda, Maryland, USA).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}